8-K
Current Report
Vistagen Therapeutics, Inc. Filed Acc 0001851734-22-000740
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading vtgn20221220_8k.htm…